NMYSF yields 11.96% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 8
Combined, NMYSF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NMYSF + MRK for your $10,000?
NamSys Inc. provides software solutions for currency management and processing for the banking and merchant industries principally in North America. The company offers Cirreon Smart Safe, a cloud-based digital platform for managing networks of smart safes; Cash in Transit Logistics that manages routes, scans barcodes, and captures signatures digitally; and Deposit Tracking for tracking digital deposit data and transmits real-time updates. It also provides Online Change Orders for simplifying the change order process; and Currency Controller, a cash vault management and logistics system. It serves financial institutions, cash-in-transit industry, and banks and armored carriers. The company was formerly known as Cencotech Inc. and changed its name to NamSys Inc. in November 2016. NamSys Inc. was incorporated in 1997 and is headquartered in Toronto, Canada.
Full NMYSF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.